Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Galderma's Epiduo gel now available in the U.S. to treat acne

Jan. 9, 2009

Peplin presents positive results from phase IIb PEP-005 trial in actinic keratosis

Jan. 9, 2009

Kythera reports positive phase II results for ATX-101 in submental fat reduction

Jan. 8, 2009

Clinuvel submits IND for confirmatory PK trial of photoprotective afamelanotide

Dec. 30, 2008

Biofrontera reports positive phase III results with BF-200 ALA in actinic keratosis

Dec. 29, 2008

Basilea commences U.S. phase III study for alitretinoin in severe hand eczema

Dec. 19, 2008

Peplin completes enrollment for its first phase III PEP-005 trial in actinic keratosis

Dec. 19, 2008

Synvista treats first patient in SYI-2074 trial for psoriasis

Dec. 17, 2008

Stelara approved in Canada for moderate to severe plaque psoriasis

Dec. 17, 2008

Capstone presents positive safety results for AZX-100 in dermal scarring

Dec. 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...